Horizon Therapeutics PLC (HZNP)

Add to Watchlists
Create an Alert
Quickflows
36.03 -0.03  -0.08% NASDAQ Jan 27, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All HZNP News

News

View All Events

Events

Date Type Description
02/27/2020 08:00 EST Misc Horizon Pharma PLC Fourth Quarter Earnings Conference Call in 2019
02/27/2020 Earnings Horizon Pharma PLC Fourth Quarter Earnings in 2019 Release
11/06/2019 08:00 EST Misc Horizon Therapeutics PLC Third Quarter Earnings Conference Call for 2019
11/06/2019 Earnings Horizon Pharma PLC Third Quarter Earnings in 2019 Release
08/07/2019 08:00 EDT Misc Horizon Pharma PLC Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Horizon Pharma PLC Second Quarter Earnings in 2019 Release
05/08/2019 08:00 EDT Misc Horizon Pharma PLC First Quarter Earnings Conference Call in 2019
05/08/2019 Earnings Horizon Pharma PLC First Quarter Earnings in 2019 Release
05/02/2019 Misc Horizon Therapeutics PLC Annual General Meeting in 2018
02/27/2019 08:00 EST Misc Horizon Pharma PLC Fourth Quarter Earnings Conference Call in 2018
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 1.292B
Total Expenses (TTM) 1.178B
Net Income (TTM) 46.09M

Balance Sheet View Statement

Total Assets (Quarterly) 3.721B
Total Liabilities (Quarterly) 2.166B
Shareholders Equity (Quarterly) 1.556B

Cash Flow Statement View Statement

Cash from Operations (TTM) 343.66M
Cash from Investing (TTM) 25.78M
Cash from Financing (TTM) -293.29M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.horizonpharma.com
  • Investor Relations URL: http://ir.horizon-pharma.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: Feb. 27, 2020
  • Last Earnings Release: Nov. 06, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the primary care segment. It markets medicines in the areas of orphan diseases, rheumatology and primary care. The majority of revenue is generated in the United States.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 36.03
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
XPH SPDR® S&P Pharmaceuticals ETF 4.47%
PJP Invesco Dynamic Pharmaceuticals ETF 3.07%
IHE iShares US Pharmaceuticals ETF 2.64%
WSMRX William Blair Small-Mid Cap Growth R6 2.36%
GTCSX Glenmede Small Cap Equity Adv 2.28%
FXH First Trust Health Care AlphaDEX® ETF 2.27%
CEARX Columbia Acorn Adv 1.65%
FTHAX Fuller & Thaler Behavioral Sm-Cp Eq A 1.56%
JGLYX JPMorgan Small Cap Growth R4 1.35%
IBB iShares Nasdaq Biotechnology ETF 0.85%
DFSTX DFA US Small Cap I 0.39%
SCHA Schwab US Small-Cap ETF™ 0.24%

Comparables

Edit
ALKS Alkermes PLC
MDT Medtronic PLC
AMRN Amarin Corp PLC
MMDZF Mainstay Medical International PLC
ENDP Endo International PLC

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.